Latest Insider Transactions at Oncology Institute, Inc. (TOI)
This section provides a real-time view of insider transactions for Oncology Institute, Inc. (TOI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Oncology Institute, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Oncology Institute, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 17
2022
|
Richard A Barasch Director |
BUY
Grant, award, or other acquisition
|
Direct |
22,708
+12.12%
|
-
|
Nov 17
2022
|
Brad Hively Director |
BUY
Grant, award, or other acquisition
|
Direct |
103,469
+15.7%
|
-
|
Nov 17
2022
|
Karen Marie Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
22,708
+34.3%
|
-
|
Nov 17
2022
|
Mohit Kaushal Director |
BUY
Grant, award, or other acquisition
|
Direct |
22,708
+32.01%
|
-
|
Nov 17
2022
|
Gabriel Ling Director |
BUY
Grant, award, or other acquisition
|
Direct |
29,057
+50.0%
|
-
|
Nov 17
2022
|
Anne Mc George Director |
BUY
Grant, award, or other acquisition
|
Direct |
22,708
+33.49%
|
-
|
Nov 17
2022
|
Matthew P Miller Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
23,607
+18.85%
|
-
|
Nov 17
2022
|
Maeve O'Meara Director |
BUY
Grant, award, or other acquisition
|
Direct |
22,708
+34.72%
|
-
|
Nov 17
2022
|
Mark L Pacala Director |
BUY
Grant, award, or other acquisition
|
Direct |
31,217
+15.07%
|
-
|
Nov 17
2022
|
Yale Podnos Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,164
+19.83%
|
-
|
Nov 17
2022
|
Ravi Yang Sarin Director |
BUY
Grant, award, or other acquisition
|
Direct |
22,708
+33.1%
|
-
|
Nov 17
2022
|
Mihir Shah Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,602
+26.83%
|
-
|
Nov 17
2022
|
Diona Simoneit Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,387
+20.74%
|
-
|
Nov 17
2022
|
Daniel Virnich Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,101
+12.78%
|
-
|
Nov 15
2022
|
Brad Hively Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
9,718
-2.1%
|
$19,436
$2.03 P/Share
|
Nov 15
2022
|
Matthew P Miller Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
577
-0.73%
|
$1,154
$2.03 P/Share
|
Nov 15
2022
|
Yale Podnos Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
199
-0.46%
|
$398
$2.03 P/Share
|
Nov 15
2022
|
Diona Simoneit Chief Accounting Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
190
-0.64%
|
$380
$2.03 P/Share
|
Nov 15
2022
|
Daniel Virnich Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,767
-1.59%
|
$7,534
$2.03 P/Share
|
Nov 14
2022
|
Mohit Kaushal Director |
SELL
Open market or private sale
|
Direct |
15,994
-38.51%
|
$31,988
$2.13 P/Share
|
Nov 11
2022
|
Havencrest Healthcare Partners, L.P. |
SELL
Open market or private sale
|
Indirect |
365,321
-2.66%
|
$730,642
$2.33 P/Share
|
Nov 10
2022
|
Havencrest Healthcare Partners, L.P. |
SELL
Open market or private sale
|
Indirect |
61,281
-0.44%
|
$122,562
$2.98 P/Share
|
Nov 09
2022
|
Havencrest Healthcare Partners, L.P. |
SELL
Open market or private sale
|
Indirect |
80,000
-0.58%
|
$240,000
$3.09 P/Share
|
Nov 08
2022
|
Havencrest Healthcare Partners, L.P. |
SELL
Open market or private sale
|
Indirect |
27,000
-0.19%
|
$81,000
$3.24 P/Share
|
Nov 07
2022
|
Havencrest Healthcare Partners, L.P. |
SELL
Open market or private sale
|
Indirect |
19,167
-0.14%
|
$57,501
$3.28 P/Share
|
Nov 04
2022
|
Havencrest Healthcare Partners, L.P. |
SELL
Open market or private sale
|
Indirect |
50,200
-0.36%
|
$150,600
$3.39 P/Share
|
Nov 03
2022
|
Havencrest Healthcare Partners, L.P. |
SELL
Open market or private sale
|
Indirect |
45,500
-0.32%
|
$136,500
$3.58 P/Share
|
Nov 02
2022
|
Havencrest Healthcare Partners, L.P. |
SELL
Open market or private sale
|
Indirect |
58,500
-0.42%
|
$175,500
$3.94 P/Share
|
Nov 01
2022
|
Havencrest Healthcare Partners, L.P. |
SELL
Open market or private sale
|
Indirect |
50,272
-0.36%
|
$201,088
$4.26 P/Share
|
Oct 31
2022
|
Havencrest Healthcare Partners, L.P. |
SELL
Open market or private sale
|
Indirect |
41,855
-0.3%
|
$167,420
$4.69 P/Share
|
Oct 28
2022
|
Havencrest Healthcare Partners, L.P. |
SELL
Open market or private sale
|
Indirect |
52,091
-0.37%
|
$208,364
$4.84 P/Share
|
Oct 27
2022
|
Havencrest Healthcare Partners, L.P. |
SELL
Open market or private sale
|
Indirect |
35,000
-0.25%
|
$175,000
$5.09 P/Share
|
Oct 26
2022
|
Havencrest Healthcare Partners, L.P. |
SELL
Open market or private sale
|
Indirect |
52,500
-0.37%
|
$262,500
$5.16 P/Share
|
Oct 25
2022
|
Havencrest Healthcare Partners, L.P. |
SELL
Open market or private sale
|
Indirect |
30,400
-0.21%
|
$152,000
$5.1 P/Share
|
Oct 24
2022
|
Havencrest Healthcare Partners, L.P. |
SELL
Open market or private sale
|
Indirect |
29,400
-0.2%
|
$117,600
$4.98 P/Share
|
Oct 24
2022
|
Mohit Kaushal Director |
SELL
Open market or private sale
|
Direct |
4,798
-10.36%
|
$19,192
$4.96 P/Share
|
Oct 21
2022
|
Havencrest Healthcare Partners, L.P. |
SELL
Open market or private sale
|
Indirect |
20,000
-0.14%
|
$80,000
$4.96 P/Share
|
Oct 20
2022
|
Havencrest Healthcare Partners, L.P. |
SELL
Open market or private sale
|
Indirect |
12,000
-0.08%
|
$48,000
$4.83 P/Share
|
Oct 19
2022
|
Havencrest Healthcare Partners, L.P. |
SELL
Open market or private sale
|
Indirect |
17,500
-0.12%
|
$70,000
$4.68 P/Share
|
Oct 18
2022
|
Havencrest Healthcare Partners, L.P. |
SELL
Open market or private sale
|
Indirect |
12,200
-0.08%
|
$48,800
$4.63 P/Share
|
Oct 17
2022
|
Havencrest Healthcare Partners, L.P. |
SELL
Open market or private sale
|
Indirect |
8,249
-0.06%
|
$32,996
$4.6 P/Share
|
Oct 14
2022
|
Havencrest Healthcare Partners, L.P. |
SELL
Open market or private sale
|
Indirect |
9,800
-0.07%
|
$39,200
$4.54 P/Share
|
Oct 13
2022
|
Havencrest Healthcare Partners, L.P. |
SELL
Open market or private sale
|
Indirect |
25,200
-0.17%
|
$100,800
$4.67 P/Share
|
Oct 12
2022
|
Havencrest Healthcare Partners, L.P. |
SELL
Open market or private sale
|
Indirect |
14,343
-0.1%
|
$57,372
$4.7 P/Share
|
Oct 11
2022
|
Havencrest Healthcare Partners, L.P. |
SELL
Open market or private sale
|
Indirect |
25,000
-0.17%
|
$100,000
$4.66 P/Share
|
Oct 10
2022
|
Havencrest Healthcare Partners, L.P. |
SELL
Open market or private sale
|
Indirect |
21,500
-0.15%
|
$86,000
$4.33 P/Share
|
Oct 07
2022
|
Havencrest Healthcare Partners, L.P. |
SELL
Open market or private sale
|
Indirect |
14,652
-0.1%
|
$58,608
$4.63 P/Share
|
Oct 06
2022
|
Havencrest Healthcare Partners, L.P. |
SELL
Open market or private sale
|
Indirect |
33,509
-0.23%
|
$134,036
$4.45 P/Share
|
Oct 05
2022
|
Havencrest Healthcare Partners, L.P. |
SELL
Open market or private sale
|
Indirect |
14,060
-0.1%
|
$56,240
$4.78 P/Share
|
Oct 05
2022
|
Richard A Barasch Director |
BUY
Other acquisition or disposition
|
Indirect |
8
+50.0%
|
-
|